T1 mapping in ischaemic heart disease.
-
h-Ici DO
Department of Congenital Heart Disease and Pediatric Cardiology, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, Berlin 13353, Germany Division of Imaging Sciences and Biomedical Engineering, St Thomas' Hospital, 4th Floor, Lambeth Wing, Westminster Bridge Road, London SE1 7EH, UK darachohici@gmail.com.
-
Jeuthe S
Department of Congenital Heart Disease and Pediatric Cardiology, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, Berlin 13353, Germany.
-
Al-Wakeel N
Department of Congenital Heart Disease and Pediatric Cardiology, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, Berlin 13353, Germany.
-
Berger F
Department of Congenital Heart Disease and Pediatric Cardiology, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, Berlin 13353, Germany.
-
Kuehne T
Department of Congenital Heart Disease and Pediatric Cardiology, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, Berlin 13353, Germany.
-
Kozerke S
Division of Imaging Sciences and Biomedical Engineering, St Thomas' Hospital, 4th Floor, Lambeth Wing, Westminster Bridge Road, London SE1 7EH, UK Institute for Biomedical Engineering, University and ETH Zurich, Gloriastrasse 35, Zürich 8092, Switzerland.
-
Messroghli DR
Department of Congenital Heart Disease and Pediatric Cardiology, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, Berlin 13353, Germany Department of Internal Medicine/Cardiology, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, Berlin 13353, Germany.
Show more…
Published in:
- European heart journal cardiovascular Imaging. - 2014
English
A unique feature of cardiac magnetic resonance is its ability to characterize myocardium. Proton relaxation times, T1, T2, and T2* are a reflection of the composition of individual tissues, and change in the presence of disease. Research into T1 mapping has largely been focused in the study of cardiomyopathies, but T1 mapping also shows huge potential in the study of ischaemic heart disease. In fact, the first cardiac T1 maps were used to characterize myocardial infarction. Robust high-resolution myocardial T1 mapping is now available for use as a clinical tool. This quantitative technique is simple to perform and analyse, minimally subjective, and highly reproducible. This review aims to summarize the present state of research on the topic, and to show the clinical potential of this method to aid the diagnosis and treatment of patients with ischaemic heart disease.
-
Language
-
-
Open access status
-
bronze
-
Identifiers
-
-
Persistent URL
-
https://folia.unifr.ch/global/documents/223236
Statistics
Document views: 10
File downloads: